Abstract | BACKGROUND: METHODS: We enrolled 76 CKD patients (age, 46.7+/-14.3 years, 39 females) and 15 controls (age, 40.1+/-18.5 years, 6 females). Clinical parameters, blood biochemistry and echocardiographic findings were recorded, and plasma ADMA concentrations measured by high-performance liquid chromatography-mass spectrometry (HPLC-MS). Patients were prospectively followed up for a median of 15 (range, 6-24) months. RESULTS: Plasma ADMA was significantly elevated in CKD patients compared with controls (41.56+/-12.76 microg/mL vs 17.12+/-7.09 microg/mL, P<0.001), and correlated with the left ventricular mass index (LVMI) (r=0.597, P<0.001). During follow-up, 25 patients experienced new CV events and their plasma ADMA level was significantly elevated (48.27+/-13.70 vs 34.91+/-6.38 in CV event-free patients, P<0.001). Cox regression analysis further confirmed that ADMA was an independent risk factor for CVD (HR=1.175, 95%CI[1.070-1.290], P=0.001). CONCLUSION: Similar to findings in ESRD patients, elevated circulating levels of ADMA may increase the risk of LVH and CV events in pre-dialysis CKD patients.
|
Authors | Beili Shi, Zhaohui Ni, Wenyan Zhou, Zanzhe Yu, Leyi Gu, Shan Mou, Wei Fang, Qin Wang, Liou Cao, Yucheng Yan, Jiaqi Qian |
Journal | European journal of internal medicine
(Eur J Intern Med)
Vol. 21
Issue 5
Pg. 444-8
(Oct 2010)
ISSN: 1879-0828 [Electronic] Netherlands |
PMID | 20816602
(Publication Type: Journal Article)
|
Copyright | Copyright (c) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- N,N-dimethylarginine
- Arginine
|
Topics |
- Adult
- Arginine
(analogs & derivatives, blood)
- Female
- Follow-Up Studies
- Humans
- Hypertrophy, Left Ventricular
(blood, epidemiology)
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- Prospective Studies
- Renal Dialysis
- Renal Insufficiency, Chronic
(blood, epidemiology)
- Risk Factors
|